Patents by Inventor Peter Andreasen

Peter Andreasen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pai-1 determination and use thereof
    Publication number: 20020012950
    Abstract: A monoclonal antibody which binds a human endothelial type plasminogen activator inhibitor (PAI-1) produced by dexamethasone-treated human HT-1080 fibrosarcoma cells may be used, inter alia, for determining PAI-1 protein abundance in tumor tissue or a sample of a body fluid. Measurements of this parameter may be useful in predicting the presence or metastasis of a tumor, or of predicting the progression of a known malignant tumor.
    Type: Application
    Filed: August 7, 2001
    Publication date: January 31, 2002
    Inventors: Lars S. Nielsen, Peter Andreasen, Keld Dano, Nils Brunner
  • PAI-1 determination and use thereof
    Patent number: 6271352
    Abstract: a monoclonal antibody which binds a human endothelial type plasminogen activator inhibitor (PAI-1) produced by dexamethasone-treated human HT-1080 fibrosarcoma cells may be used, inter alia, for determining PAI-1 protein abundance in tumor tissue or a sample of a body fluid. Measurements of this parameter may be useful in predicting the presence or metastasis of a tumor, or of predicting the progression of a known malignant tumor.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: August 7, 2001
    Assignee: Fonden til Fremme af Eksperimentel Cancerforskning
    Inventors: Lars S. Nielsen, Peter Andreasen, Keld Dano, Nils Brunner